TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Ilika plc ( (GB:IKA) ).
Ilika plc has made significant progress in its solid-state battery technology, with key advancements in both its Stereax and Goliath product lines. The Stereax M300 micro-battery production line has been qualified for manufacturing at Cirtec Medical’s facility, marking a crucial step towards meeting the demand for medical-grade micro-batteries. Meanwhile, the Goliath 2Ah P1 cells have been validated by customer testing, and the company has secured a £1.25 million grant to support the development of automotive applications. The completion of an automated assembly line for Goliath batteries enhances production capabilities, positioning Ilika to release 10Ah prototypes by December 2025. Despite a decrease in revenue and an increase in EBITDA loss, these developments underscore Ilika’s commitment to advancing its battery technology and expanding its market presence.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £40.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Spark’s Take on GB:IKA Stock
According to Spark, TipRanks’ AI Analyst, GB:IKA is a Neutral.
Ilika plc’s overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and negative profitability. Technical analysis provides some support with mild positive momentum, but valuation remains unattractive due to negative earnings. The absence of earnings call data and corporate events limits further insights.
To see Spark’s full report on GB:IKA stock, click here.
More about Ilika plc
Ilika plc is a global leader in the development of solid-state battery technology, catering to industries such as electric vehicles, medical devices, and consumer appliances. The company offers two main product lines: Stereax batteries for miniature medical implants and IoT applications, and Goliath batteries for electric vehicles and cordless appliances. Ilika operates on a licensing business model, providing its intellectual property to OEMs and manufacturing partners for license fees and future royalties.
Average Trading Volume: 221,457
Technical Sentiment Signal: Buy
Current Market Cap: £83.18M
For detailed information about IKA stock, go to TipRanks’ Stock Analysis page.